Monoclonal antibodies to hepatocyte growth factor

Details Monoclonal antibodies to hepatocyte growth factor Monoclonal antibodies to hepatocyte growth factor

2007-05-22

2007-05-22

Li, Ruixiang (Department: 1646)

Drug, bio-affecting and body treating compositions

Immunoglobulin, antiserum, antibody, or antibody fragment,...

Structurally-modified antibody, immunoglobulin, or fragment...

C424S141100, C530S387300, C530S388100, C435S326000

Reexamination Certificate

active

10917915

ABSTRACT:
The present invention is directed toward a neutralizing monoclonal antibody to hepatocyte growth factor, a pharmaceutical composition comprising same, and methods of treatment comprising administering such a pharmaceutical composition to a patient.

REFERENCES:
patent: 5004805 (1991-04-01), Gohda et al.
patent: 5707624 (1998-01-01), Nickoloff et al.
patent: 5997868 (1999-12-01), Goldberg et al.
patent: 6214344 (2001-04-01), Schwall et al.
patent: 6432406 (2002-08-01), Goldberg et al.
patent: WO 2005/017107 (2005-02-01), None
patent: WO 2002/044848 (2005-05-01), None
Hayashi, et al. Biochem. Biophys. Res. Comm. 220: 539-545, 1996 ‘Autocrine-Paracrine Effects of Overexpression of Heptocyte Growth Factor Gene on Growth of Endothelial Cells’.
Monoclonal Anti-human HGF Antibody, brochure dated Jun. 3, 2002 by R & D Systems downloaded from WWW.mdsystems.com/pdf/MAF284.pdf.
Anti-Human Hepatocyte Growth Factor (HGF) Developed in Goat, Affinity Isolated Antibody, product No. H7157, brochure for Sigma®.
Birchmeier et al., “Met, Metastasis, Motility and More,”Nature Reviews, 4:915-925 (2003).
Cao et al., “Neutralizing monoclonal antibodies to hepatocyte growth factor / scatter factor (HGF / SF) display antitumor activity in animal models,”PNAS, 98(13):7443-7448 (2001).
Danilkovitch-Miagkova et al., “Dysregulation of Met receptor tyrosine kinase activity in invasive tumors,”J. Clinical Investigation, 109(7):863-867 (2002).
Date et al., “Inhibition of tumor growth and invasion by a four kringle antagonist (HGF / NK4) for hepatocyte growth factor,”Oncogene, 17:3045-3054 (1998).
Koochekpour et al., “Met and Hepatocyte Growth Factor/Scatter Factor Expression in Human Gliomas(1),”Cancer Research, 57:5391-5398 (1997).
Kuba et al., “HGF/NK4, a Four-Kringle Antagonist of Hepatocyte Growth Factor, Is an Angiogenesis Inhibitor that Suppresses Tumor Growth and Metastasis in Mice,”Cancer Research, 60:6737-6743 (2000).
Maulik et al., “Role of the hepatocyte growth factor receptor, c-Met, in oncogenesis and potential for therapeutic inhibition,”Cytokine & Growth Factor Reviews, 13:41-59 (2002).
Prat et al., “Agonistic monoclonal antibodies against the Met receptor dissect the biological responses to HGF,”Journal of Cell Science, 111:237-247 (1998).
Schwall et al., “Inhibition of cmet activation by a one-armed antibody,”Proceedings of AACR, # 1424 from vol. 45 (2004).
Zaccolo et al., “Dimerization of Fab fragments enables ready screening of phage antibodies that affect hepatocyte growth factor/scatter factor activity on target cells,”Eur. J. Immunol.,27:618-623 (1997).
Burr et al., “Anti-Hepatocyte Growth Factor Antibody Inhibits Hepatocyte Proliferation During Liver Regeneration,”J. Pathology, 185:298-302 (1998).
Di Nicola et al., “Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli,”Blood, 99(10):3838-3843 (2002).

Affiliated with

Also associated with

Rating

Monoclonal antibodies to hepatocyte growth factor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Monoclonal antibodies to hepatocyte growth factor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Monoclonal antibodies to hepatocyte growth factor will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3766192